Could VGF and/or its derived peptide act as biomarkers for the diagnosis of neurodegenerative diseases: A systematic review
BackgroundThe increasing ageing population has led to an increase in the prevalence of neurodegenerative diseases, such as Alzheimer’s disease (AD), Parkinson’s disease (PD), and amyotrophic lateral sclerosis (ALS). However, as yet, there are no simple biomarkers to predict the onset of such disease...
Salvato in:
| Autori principali: | , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Frontiers Media S.A.
2022-12-01
|
| Serie: | Frontiers in Endocrinology |
| Soggetti: | |
| Accesso online: | https://www.frontiersin.org/articles/10.3389/fendo.2022.1032192/full |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|